| Aditx is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. Co.'s immune reprogramming technology is at the pre-clinical stage and designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. Co.'s immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. We show 7 historical shares outstanding datapoints in our coverage of ADTX's shares outstanding history.|
Understanding the changing numbers of ADTX shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ADTX versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ADTX by allowing them to research ADTX shares outstanding history
as well as any other stock in our coverage universe.